The continuum of breast cancer care and outcomes in the U.S. Military Health System: an analysis by benefit type and care source
- 97 Downloads
This study investigates transition rates between breast cancer diagnosis, recurrence, and death by insurance benefit type and care source in U.S. Military Health System (MHS).
The MHS data repository and central cancer registry linked data were used to identify women aged 40–64 with histologically confirmed breast cancer between 2003 and 2007. Three-state continuous time Markov models were used to estimate transition rates and transition rate ratios (TRRs) by TRICARE benefit type (Prime or non-Prime) and care source (direct, purchased, or both), adjusted for demographic, tumor, and treatment variables.
Analyses included 2668 women with transitions from diagnosis to recurrence (n = 832), recurrence to death (n = 79), and diagnosis to death without recurrence (n = 91). Compared to women with Prime within each care source, women with non-Prime using both care sources had higher transition rates (TRR 1.47, 95% CI 1.03, 2.10). Compared to those using direct care within each benefit type, women utilizing both care sources with non-Prime had higher transition rates (TRR 1.86, 95% CI 1.11, 3.13), while women with Prime utilizing purchased care had lower transition rates (TRR 0.82, 95% CI 0.68, 0.98).
In the MHS, women with non-Prime benefit plans compared to Prime had higher transition rates along the breast cancer continuum among both care source users. Purchased care users had lower transition rates than direct care users among Prime beneficiaries.
Implications for Cancer Survivors
Benefit plan and care source may be associated with breast cancer progression. Further research is needed to demonstrate differences in survivorship.
KeywordsHealth services Breast cancer Insurance Recurrence Survival
This project was supported by the John P. Murtha Cancer Center, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center under the auspices of the Henry M. Jackson Foundation for the Advancement of Military Medicine. The original data linkage was supported by the former United States Military Cancer Institute and Division of Cancer Epidemiology and Genetics, National Cancer Institute. The authors thank the following institutes for their contributions to the original data linkage project: ICF Macro, Kennel and Associates, Inc., the Defense Health Agency, the Joint Pathology Center and former Armed Forces Institute of Pathology, and the National Cancer Institute.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views, assertions, opinions, or policies of the Uniformed Services University of the Health Sciences (USUHS), the Department of Defense (DoD), or the Departments of the Army, Navy, or Air Force. Mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government.
- 1.Hassett MJ, Neville BA, Weeks JC. The relationship between quality, spending and outcomes among women with breast cancer. J Natl Cancer Inst. 2014;106(10).Google Scholar
- 2.Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Mell LK, et al. The impact of radiotherapy costs on clinical outcomes in breast cancer. Radiother Oncol. 2015;117(2):393–9.Google Scholar
- 3.Rong X, Yang W, Garzon-Muvdi T, Caplan JM, Hui X, Lim M, et al. Influence of insurance status on survival of adults with glioblastoma multiforme: a population-based study. Cancer. 2016;122:3157–65. https://doi.org/10.1002/cncr.30160.
- 4.Naghavi AO, Echevarria MI, Grass GD, Strom TJ, Abuodeh YA, Ahmed KA, et al. Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies. Cancer. 2016;122:3529–37. https://doi.org/10.1002/cncr.30212.
- 6.Landrum MB, Keating NL, Lamont EB, Bozeman SR, Krasnow SH, Shulman L, et al. Survival of older patients with cancer in the veterans health administration versus fee-for-service Medicare. J Clin Oncol. 2012;30(10):1072–9. https://doi.org/10.1200/jco.2011.35.6758.
- 7.Wang CJ, Cheng SH, Wu JY, Lin YP, Kao WH, Lin CL, et al. Association of a Bundled-Payment Program with cost and outcomes in full-cycle breast cancer care. JAMA Oncology. 2017;3(3):327–34. https://doi.org/10.1001/jamaoncol.2016.4549.
- 9.Defense Health Agency. TRICARE. 2016. www.tricare.mil.
- 10.Jansen DJ. Military Medical Care: Questions and Answers. In: Congressional Research Service, editor. www.crs.gov2014.
- 12.Li YP, Chan W. Analysis of longitudinal multinomial outcome data. Biometrical journal Biometrische Zeitschrift. 2006;48(2):319–26.Google Scholar
- 17.American Joint Committee on Cancer. Breast. In: Eds. F.L. Greene, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG et al., editors. AJCC Cancer Staging Manual. Sixth Edition ed. United States of America: Springer; 2002. p. 223–40.Google Scholar
- 18.Stokes ME, Thompson D, Montoya EL, Weinstein MC, Winer EP, Earle CC. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data. Value in health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research. 2008;11(2):213–20.CrossRefGoogle Scholar
- 19.TRICARE Management Activity, Office of the Chief Financial Officer-Defense Health Cost Assessment and Program Evaluation. Evaluation of the TRICARE Program: Access, Cost, and Quality. http://www.tricare.mil/tma/studeiseval.aspx2012.
- 20.Defense Health Agency, Defense Health Cost Assessment and Program Evaluation. Evaluation of the TRICARE Program: Access, Cost, and Quality. http://www.tricare.mil/tma/studieseval.aspx2014.
- 25.Schinkel JK, Zahm SH, Jatoi I, McGlynn KA, Gallagher C, Schairer C, et al. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the surveillance, epidemiology, and end results data. Cancer Causes Control. 2014;25(8):959–68. https://doi.org/10.1007/s10552-014-0395-1.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. 2017. www.nccn.org. Accessed: 6 April 2017.